Nutex Health Analyst Price Targets - Benzinga

Nutex Health Inc

NUTXNASDAQ

Trade with Public

Trade with Public

$193.24

-4.44-2.25%

In chiusura: Sep 4, 5:00 PM EST

$193.24

N/A

Post-mercato: 4:00 PM EST

Panoramica Notizie Previsioni utili EventiObiettivi di prezzoDati finanziari Sentiment Azionariato Confronta Rapporto azionario

Nutex Health Analyst Price Targets

Wall Street analyst price targets and consensus rating for Nutex Health (NUTX).

Price Target Range — 9 Quarters

Analyst Consensus — 4 Analysts

4Buy

Consensus RatingBuy# Analysts4Avg. Consensus PT$286Upside to Avg. PT+48.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 4, 2026	B. Riley Securities	Yuan Zhi	PT Raise	Buy	$290→$325
Aug 11, 2026	Lake Street	Ben Haynor	PT Raise	Buy	$235→$310
Jun 26, 2026	B. Riley Securities	Anderson Schock	Initiate	Buy	$290
Jun 2, 2026	Lake Street	Ben Haynor	Initiate	Buy	$235
Aug 26, 2025	Maxim Group	Anthony Vendetti	PT Cut	Buy	$225→$205
Jul 10, 2025	Benchmark	Bill Sutherland	Maintained	Buy	$300
May 20, 2025	Maxim Group	Anthony Vendetti	PT Raise	Buy	$100→$225
May 15, 2025	Benchmark	Bill Sutherland	PT Raise	Buy	$150→$300
Apr 9, 2025	Benchmark	Bill Sutherland	PT Raise	Buy	$60→$150
Apr 8, 2025	Maxim Group	Anthony Vendetti	PT Raise	Buy	$75→$100
Feb 13, 2025	Maxim Group	Anthony Vendetti	PT Raise	Buy	$50→$75
Nov 12, 2024	Maxim Group	Anthony Vendetti	PT Raise	Buy	$45→$50
Nov 12, 2024	Benchmark	Bill Sutherland	PT Raise	Buy	$45→$60
Sep 18, 2024	Maxim Group	Anthony Vendetti	Initiate	Buy	$45
Aug 21, 2024	Benchmark	Bill Sutherland	PT Raise	Buy	$30→$45
Jan 25, 2024	Benchmark	Bill Sutherland	PT Cut	Buy	$2→$1
Nov 14, 2023	Benchmark	Bill Sutherland	PT Cut	Buy	$3→$2

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
B. Riley Securities Maintains Buy on Nutex Health, Raises Price Target to $325

B. Riley Securities analyst Yuan Zhi maintains Nutex Health (NASDAQ:NUTX) with a Buy and raises the price target from $290 to $325.

Benzinga Newsdesk

PRO
Lake Street Maintains Buy on Nutex Health, Raises Price Target to $310

Lake Street analyst Ben Haynor maintains Nutex Health (NASDAQ:NUTX) with a Buy and raises the price target from $235 to $310.

Benzinga Newsdesk

PRO
B. Riley Securities Initiates Coverage On Nutex Health with Buy Rating, Announces Price Target of $290

B. Riley Securities analyst Anderson Schock initiates coverage on Nutex Health (NASDAQ:NUTX) with a Buy rating and announces Price Target of $290.

Benzinga Newsdesk

PRO
Lake Street Initiates Coverage On Nutex Health with Buy Rating, Announces Price Target of $235

Lake Street analyst Ben Haynor initiates coverage on Nutex Health (NASDAQ:NUTX) with a Buy rating and announces Price Target of $235.

Benzinga Newsdesk

PRO
Maxim Group Maintains Buy on Nutex Health, Lowers Price Target to $205

Maxim Group analyst Anthony Vendetti maintains Nutex Health (NASDAQ:NUTX) with a Buy and lowers the price target from $225 to $205.

Benzinga Newsdesk

PRO
Benchmark Maintains Buy on Nutex Health, Raises Price Target to $300

Benchmark analyst Bill Sutherland maintains Nutex Health (NASDAQ:NUTX) with a Buy and raises the price target from $150 to $300.

Benzinga Newsdesk